Schonfeld Strategic Advisors’s GoodRx Holdings GDRX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-65,616	Closed	-$369K	–	1998
2023 Q3	$369K	Buy	65,616 +43,610	+198%	+$291K	﹤0.01%	1287
2023 Q2	$121K	Buy	22,006 +10,151	+86%	+$54.6K	﹤0.01%	1688
2023 Q1	$74.1K	Sell	11,855 -93,241	-89%	-$520K	﹤0.01%	1736
2022 Q4	$490K	Sell	105,096 -45,504	-30%	-$224K	﹤0.01%	1537
2022 Q3	$703K	Sell	150,600 -373,743	-71%	-$2.36M	0.01%	1511
2022 Q2	$3.1M	Buy	+524,343	New	+$5.84M	0.03%	614
2021 Q1	–	Sell	-49,835	Closed	-$2.01M	–	1915
2020 Q4	$2.01M	Buy	49,835 +46,055	+1,218%	+$2.12M	0.03%	594
2020 Q3	$210K	Buy	+3,780	New	+$200K	﹤0.01%	1208

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schonfeld Strategic Advisors's GDRX Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 65,616 shares — an estimated $369K sold.

Schonfeld Strategic Advisors first reported a position in GDRX in Q3 2020 and held it in 8 quarters. The position peaked at $3.1M in Q2 2022. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

Schonfeld Strategic Advisors reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 65,616 GoodRx Holdings shares in Q4 2023, an estimated $369K.
Schonfeld Strategic Advisors first reported a position in GoodRx Holdings in Q3 2020 and held it in 8 quarters.
Schonfeld Strategic Advisors's GoodRx Holdings position peaked at $3.1M in Q2 2022.
143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.